This can change how well the medicine works and may lead to different effects
[DOI] [PubMed] [Google Scholar] 47.Naka T, Narazaki M, Hirata M, et al
Total weekly exposure (AUC) stays roughly the same
Indeed, GLP-1RAs have evolved over time such that the frequency of dosing has decreased from twice-daily (exenatide, BD) [65], to once-daily (liraglutide, lixisenatide) [66, 67] to once-weekly (dulaglutide, exenatide QW, semaglutide) [5, 6], suggesting a higher adherence potential for the longer-acting agents (Table 2)
The goal is to reach a maintenance dose that supports long-term blood sugar control and weight loss
A licensed California provider will make the final determination following a thorough online medical evaluation